鬱血除去剤の世界市場レポート 2025年

鬱血除去剤市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.1%で289億4,000万米ドルに成長します。予測期間中の成長は、配合剤需要の増加、新興市場におけるヘルスケアアクセスの改善、点鼻薬への嗜好の高まり、高齢者の拡大、オンライン薬局の普及の高まりなどに起因すると考えられます。この期間に予想される主要動向には、ドラッグデリバリーシステムの技術的発展、小児用製剤の革新、徐放性製剤の開発、アレルギーに特化した治療法の研究開発、天然薬草代替品の革新などがあります。

アレルギー、風邪、副鼻腔炎の罹患率の増加は、鬱血除去剤市場の今後の成長を促進すると予想されます。アレルギーは無害な物質に対する免疫反応であり、風邪は呼吸器症状を引き起こすウイルス感染症であり、副鼻腔炎は多くの場合、感染症やアレルギーによって引き起こされる副鼻腔の炎症です。これらの症状の増加は、大気汚染や環境刺激物質の増加に関連しています。鬱血除去剤は、鼻づまりを緩和し、鼻腔の炎症を抑え、空気の流れを改善し、呼吸困難を和らげ、患者の快適性を高めることによって、アレルギー、風邪、副鼻腔炎を管理するのに役立ちます。例えば、2023年12月、米国の非営利団体USAFactsは、2022～2023年の米国インフルエンザシーズン中、約3,190万人がインフルエンザの症状を経験し、その85％近くが10月から1月の間に発症したと報告しました。このように、アレルギー、風邪、副鼻腔炎の罹患率の上昇が、鬱血除去剤市場の成長を促進しています。

鬱血除去剤市場の主要企業は、鼻づまりを迅速かつ効果的に緩和し、使用者の快適性と治療効果を向上させるため、即効性スプレーなどの市販鼻腔充血除去剤の製品拡大に注力しています。即効性スプレーとは、使用後すぐに鼻づまりを素早く軽減することで、迅速な緩和を提供する点鼻薬のことです。例えば、2024年8月、英国の製薬会社であるマンクスヘルスケア社は、呼吸器ケア・ポートフォリオを成長させる戦略の一環として、キシロメタゾリン鼻づまり解消スプレーを発売しました。この即効性のある市販製品は、風邪、副鼻腔炎、アレルギー性鼻炎などの症状によって引き起こされる鼻づまりを緩和するために特別に設計されています。今回の発売は、手軽で高品質なセルフケア治療を提供する一方、迅速かつ長期的な緩和と使いやすさを実現する効果的な鬱血除去剤に対する消費者の需要の高まりに応えるという、同社の献身的な姿勢を浮き彫りにするものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の鬱血除去剤：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の鬱血除去剤市場：成長率分析
• 世界の鬱血除去剤市場の実績：規模と成長、2019～2024年
• 世界の鬱血除去剤市場の予測：規模と成長、2024～2029年、2034年
• 世界の鬱血除去剤：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の鬱血除去剤市場：製品タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 錠剤
• カプセル
• 鼻スプレー
• その他の製品タイプ
• 世界の鬱血除去剤市場：送達メカニズム別、実績と予測、2019～2024年、2024～2029年、2034年
• 局所投与
• 経口投与
• 吸入
• 世界の鬱血除去剤市場：原料別、実績と予測、2019～2024年、2024～2029年、2034年
• 合成鬱血除去剤
• 天然（植物由来）鬱血除去剤
• 世界の鬱血除去剤市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 季節性アレルギー性鼻炎
• 通年性アレルギー性鼻炎
• 副鼻腔炎
• 鼻づまり
• 風邪とインフルエンザ
• その他
• 世界の鬱血除去剤市場：エンドユーザー用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 薬局またはドラッグストア
• オンライン小売
• 病院とクリニック
• スーパーマーケットまたはハイパーマーケット
• 世界の鬱血除去剤市場、錠剤のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 即放錠
• 徐放錠
• 配合錠
• 世界の鬱血除去剤市場、カプセルのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ソフトジェルカプセル
• ハードゼラチンカプセル
• 徐放性カプセル
• 世界の鬱血除去剤市場、鼻スプレーのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 定量噴霧式鼻腔スプレー
• 生理食塩水鼻スプレー
• ステロイド点鼻スプレー
• 世界の鬱血除去剤市場、その他の製品タイプのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ロゼンジ
• シロップ
• 吸入器

第7章 地域別・国別分析

• 世界の鬱血除去剤市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の鬱血除去剤市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 鬱血除去剤市場：競合情勢
• 鬱血除去剤市場：企業プロファイル
  • Pfizer Inc.
  • Procter & Gamble Co.
  • Johnson & Johnson
  • Bayer AG
  • Sanofi S.A.

第31章 その他の大手企業と革新的企業

• GlaxoSmithKline plc
• Teva Pharmaceutical Industries Ltd.
• Church & Dwight Co. Inc.
• Perrigo Company plc
• Dr. Reddy's Laboratories Ltd.
• Cipla Ltd.
• Helen of Troy Limited
• Prestige Consumer Healthcare Inc.
• Orifarm Group A/S
• Pharmascience Inc.
• Beximco Pharmaceuticals Ltd.
• Reckitt Benckiser Group plc
• AdvaCare Pharma
• Anish Chemicals
• Marinomed BIoTech AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 鬱血除去剤市場、2029年：新たな機会を提供する国
• 鬱血除去剤市場、2029年：新たな機会を提供するセグメント
• 鬱血除去剤市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Decongestants are drugs used to alleviate nasal congestion caused by ailments such as the common cold, allergies, or sinus infections. They function by constricting blood vessels in the nasal passages, which reduces swelling and helps open the airways for easier breathing.

The primary forms of decongestants include tablets, capsules, nasal sprays, and other types. Tablets are solid oral medications that relieve nasal congestion by shrinking swollen blood vessels in the nasal passages. Decongestants are classified by their delivery method into topical, oral, and inhalation forms, each catering to specific needs like convenience, speed of effect, and symptom severity. These products are made using various ingredients, including synthetic decongestants that provide fast and targeted relief, as well as natural, plant-based options. Decongestants are used to treat several conditions, including seasonal allergic rhinitis, perennial allergic rhinitis, sinusitis, nasal congestion, cold and flu, and other related issues. The main end-user groups comprise pharmacies or drugstores, online retail platforms, hospitals and clinics, and supermarkets or hypermarkets.

The decongestants market research report is one of a series of new reports from The Business Research Company that provides decongestants market statistics, including the decongestants industry global market size, regional shares, competitors with the decongestants market share, detailed decongestants market segments, market trends, and opportunities, and any further data you may need to thrive in the decongestants industry. This decongestants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The decongestants market size has grown strongly in recent years. It will grow from $18.63 billion in 2024 to $20.39 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth during the historic period can be attributed to the rising prevalence of the common cold, increased use of over-the-counter medications, heightened awareness of self-medication, expansion of pharmaceutical retail networks, and a growing number of allergic rhinitis cases.

The decongestants market size is expected to see strong growth in the next few years. It will grow to $28.94 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. Growth during the forecast period can be attributed to the increasing demand for combination drugs, improved healthcare access in emerging markets, a growing preference for nasal sprays, an expanding elderly population, and the rising adoption of online pharmacies. Key trends expected in this period include technological advancements in drug delivery systems, innovations in pediatric formulations, development of extended-release decongestants, research into allergy-specific treatments, and innovations in natural and herbal alternatives.

The rising incidence of allergies, colds, and sinusitis is expected to drive the growth of the decongestants market moving forward. Allergies are immune responses to harmless substances, colds are viral infections that cause respiratory symptoms, and sinusitis is inflammation of the sinuses often triggered by infections or allergies. The increase in these conditions is linked to growing air pollution and environmental irritants. Decongestants aid in managing allergies, colds, and sinusitis by relieving nasal congestion, reducing inflammation in the nasal passages, improving airflow, easing breathing difficulties, and enhancing patient comfort. For example, in December 2023, USAFacts, a US-based nonprofit organization, reported that during the 2022-2023 US flu season, about 31.9 million people experienced flu symptoms, with nearly 85% of cases occurring between October and January. Thus, the rising incidence of allergies, colds, and sinusitis is fueling growth in the decongestants market.

Leading companies in the decongestants market are focusing on expanding over-the-counter nasal decongestant offerings, such as fast-acting sprays, to provide quick and effective relief from nasal congestion, thereby improving user comfort and treatment results. A fast-acting spray is a nasal spray that offers rapid relief by quickly reducing nasal congestion soon after use. For example, in August 2024, Manx Healthcare Ltd., a UK-based pharmaceutical firm, launched the Xylometazoline Decongestant Nasal Spray as part of its strategy to grow its respiratory care portfolio. This fast-acting, over-the-counter product is specifically designed to relieve nasal congestion caused by conditions like colds, sinusitis, and allergic rhinitis. The launch highlights the company's dedication to offering accessible, high-quality self-care treatments while meeting growing consumer demand for effective decongestants that deliver rapid, long-lasting relief with ease of use.

In October 2023, Haleon plc, a UK-based pharmaceutical company, collaborated with AptarGroup Inc. to develop a new generation of nasal sprays. This partnership aims to transform nasal congestion treatment by integrating innovative microdroplet and Lateral Control System pump technologies to provide a more comfortable, effective, and user-friendly nasal spray experience. The goal is to overcome common usage barriers and improve relief for patients suffering from colds, allergic rhinitis, and sinusitis. AptarGroup, Inc., a US-based company, specializes in designing and manufacturing drug delivery and dispensing technologies, including those for nasal decongestants.

Major players in the decongestants market are Pfizer Inc., Procter & Gamble Co., Johnson & Johnson, Bayer AG, Sanofi S.A., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Church & Dwight Co. Inc., Perrigo Company plc, Dr. Reddy's Laboratories Ltd., Cipla Ltd., Helen of Troy Limited, Prestige Consumer Healthcare Inc., Orifarm Group A/S, Pharmascience Inc., Beximco Pharmaceuticals Ltd., Reckitt Benckiser Group plc, AdvaCare Pharma, Anish Chemicals, Marinomed Biotech AG.

North America was the largest region in the decongestants market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in decongestants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the decongestants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The decongestants market consists of sales of oral decongestants, topical or nasal decongestants, selective alpha-adrenergic agonists, and sympathomimetic amines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Decongestants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on decongestants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for decongestants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The decongestants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Tablets; Capsules; Nasal Sprays; Other Product Types
• 2) By Delivery Mechanism: Topical Administration; Oral Administration; Inhalation
• 3) By Source Of Ingredients: Synthetic Decongestants; Natural (Plant-Based) Decongestants
• 4) By Application: Seasonal Allergic Rhinitis; Perennial Allergic Rhinitis; Sinusitis; Nasal Congestion; Cold And Flu; Other Applications
• 5) By End-User Application: Pharmacies Or Drugstores; Online Retail; Hospitals And Clinics; Supermarkets Or Hypermarkets
• Subsegments:
• 1) By Tablets: Immediate-Release Tablets; Extended-Release Tablets; Combination Tablets
• 2) By Capsules: Soft Gel Capsules; Hard Gelatin Capsules; Sustained-Release Capsules
• 3) By Nasal Sprays: Metered-Dose Nasal Sprays; Saline Nasal Sprays; Steroidal Nasal Sprays
• 4) By Other Product Types: Lozenges; Syrups; Inhalers
• Companies Mentioned: Pfizer Inc.; Procter & Gamble Co.; Johnson & Johnson; Bayer AG; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Decongestants Market Characteristics

3. Decongestants Market Trends And Strategies

4. Decongestants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Decongestants Growth Analysis And Strategic Analysis Framework

• 5.1. Global Decongestants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Decongestants Market Growth Rate Analysis
• 5.4. Global Decongestants Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Decongestants Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Decongestants Total Addressable Market (TAM)

6. Decongestants Market Segmentation

• 6.1. Global Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Nasal Sprays
• Other Product Types
• 6.2. Global Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Administration
• Oral Administration
• Inhalation
• 6.3. Global Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Synthetic Decongestants
• Natural (Plant-Based) Decongestants
• 6.4. Global Decongestants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Seasonal Allergic Rhinitis
• Perennial Allergic Rhinitis
• Sinusitis
• Nasal Congestion
• Cold And Flu
• Other Applications
• 6.5. Global Decongestants Market, Segmentation By End-User Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacies Or Drugstores
• Online Retail
• Hospitals And Clinics
• Supermarkets Or Hypermarkets
• 6.6. Global Decongestants Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immediate-Release Tablets
• Extended-Release Tablets
• Combination Tablets
• 6.7. Global Decongestants Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Soft Gel Capsules
• Hard Gelatin Capsules
• Sustained-Release Capsules
• 6.8. Global Decongestants Market, Sub-Segmentation Of Nasal Sprays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metered-Dose Nasal Sprays
• Saline Nasal Sprays
• Steroidal Nasal Sprays
• 6.9. Global Decongestants Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lozenges
• Syrups
• Inhalers

7. Decongestants Market Regional And Country Analysis

• 7.1. Global Decongestants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Decongestants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Decongestants Market

• 8.1. Asia-Pacific Decongestants Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Decongestants Market

• 9.1. China Decongestants Market Overview
• 9.2. China Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Decongestants Market

• 10.1. India Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Decongestants Market

• 11.1. Japan Decongestants Market Overview
• 11.2. Japan Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Decongestants Market

• 12.1. Australia Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Decongestants Market

• 13.1. Indonesia Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Decongestants Market

• 14.1. South Korea Decongestants Market Overview
• 14.2. South Korea Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Decongestants Market

• 15.1. Western Europe Decongestants Market Overview
• 15.2. Western Europe Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Decongestants Market

• 16.1. UK Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Decongestants Market

• 17.1. Germany Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Decongestants Market

• 18.1. France Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Decongestants Market

• 19.1. Italy Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Decongestants Market

• 20.1. Spain Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Decongestants Market

• 21.1. Eastern Europe Decongestants Market Overview
• 21.2. Eastern Europe Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Decongestants Market

• 22.1. Russia Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Decongestants Market

• 23.1. North America Decongestants Market Overview
• 23.2. North America Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Decongestants Market

• 24.1. USA Decongestants Market Overview
• 24.2. USA Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Decongestants Market

• 25.1. Canada Decongestants Market Overview
• 25.2. Canada Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Decongestants Market

• 26.1. South America Decongestants Market Overview
• 26.2. South America Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Decongestants Market

• 27.1. Brazil Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Decongestants Market

• 28.1. Middle East Decongestants Market Overview
• 28.2. Middle East Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Decongestants Market

• 29.1. Africa Decongestants Market Overview
• 29.2. Africa Decongestants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Decongestants Market, Segmentation By Delivery Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Decongestants Market, Segmentation By Source Of Ingredients, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Decongestants Market Competitive Landscape And Company Profiles

• 30.1. Decongestants Market Competitive Landscape
• 30.2. Decongestants Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Procter & Gamble Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Decongestants Market Other Major And Innovative Companies

• 31.1. GlaxoSmithKline plc
• 31.2. Teva Pharmaceutical Industries Ltd.
• 31.3. Church & Dwight Co. Inc.
• 31.4. Perrigo Company plc
• 31.5. Dr. Reddy's Laboratories Ltd.
• 31.6. Cipla Ltd.
• 31.7. Helen of Troy Limited
• 31.8. Prestige Consumer Healthcare Inc.
• 31.9. Orifarm Group A/S
• 31.10. Pharmascience Inc.
• 31.11. Beximco Pharmaceuticals Ltd.
• 31.12. Reckitt Benckiser Group plc
• 31.13. AdvaCare Pharma
• 31.14. Anish Chemicals
• 31.15. Marinomed Biotech AG

32. Global Decongestants Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Decongestants Market

34. Recent Developments In The Decongestants Market

35. Decongestants Market High Potential Countries, Segments and Strategies

• 35.1 Decongestants Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Decongestants Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Decongestants Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer